コンテンツへスキップ
Merck
  • Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays.

Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays.

Xenobiotica; the fate of foreign compounds in biological systems (2014-07-30)
Ramakrishna Nirogi, Raghava Choudary Palacharla, Venkatesham Uthukam, Arunkumar Manoharan, Surya Rao Srikakolapu, Ilayaraja Kalaikadhiban, Rajesh Kumar Boggavarapu, Ranjith Kumar Ponnamaneni, Devender Reddy Ajjala, Gopinadh Bhyrapuneni
要旨

1. Chemical inhibition is the widely used method in reaction phenotyping assays for estimation of specific enzyme contribution to a given metabolic pathway. The results from phenotyping assays depend on the selectivity of chemical inhibitor and the concentration of inhibitor used in the incubation. 2. The higher protein concentrations used in the in vitro phenotyping assays will impact the inhibitory potency of chemical inhibitors. The objective of the study is to evaluate comprehensively the selectivity of chemical inhibitors and to guide in selecting appropriate concentration of the chemical inhibitors to be used in the phenotyping assays based on unbound fractions. 3. Selectivity of chemical inhibitors against nine major CYP450 isoforms was determined in liver microsomes using standard probe substrates. The unbound fractions of the selective inhibitors were determined in human liver microsomes using high-throughput equilibrium dialysis. Combining unbound inhibitor concentrations that are required to inhibit the CYP450 activities by 90% and unbound fractions of the chemical inhibitors in liver microsomes appropriate total concentrations of the inhibitors to be used in the phenotyping assays were reported. 4. The findings suggest that non-specific binding of the chemical inhibitors need to be taken into account while selecting concentrations for phenotyping assays.

材料
製品番号
ブランド
製品内容

USP
アセトアミノフェン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
クマリン, ≥99% (HPLC)
Sigma-Aldrich
フェナセチン, ≥98.0% (HPLC)
Supelco
アセトアミノフェン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
ウンベリフェロン, 99%
Sigma-Aldrich
ケトコナゾール, 99.0-101.0% (EP, titration)
Sigma-Aldrich
キニジン, anhydrous
Sigma-Aldrich
アセトアミノフェン, BioXtra, ≥99.0%
Sigma-Aldrich
アセトアミノフェン, analytical standard
Sigma-Aldrich
フラフィリン, ≥98% (HPLC)
Sigma-Aldrich
キニジン, crystallized, ≥98.0% (dried material, NT)
USP
フェナセチン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Azamulin, ≥98% (HPLC)
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
アセトアミノフェン, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
スルファヘナゾール, ≥98%
Sigma-Aldrich
フォメピゾール, 99%
パラセタモール, European Pharmacopoeia (EP) Reference Standard
USP
ケトコナゾール, United States Pharmacopeia (USP) Reference Standard
Supelco
フェナセチン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
クロルゾキサゾン
Sigma-Aldrich
4-ヒドロキシメフェニトイン
Sigma-Aldrich
ウンベリフェロン, suitable for fluorescence indicator, ≥98.0% (HPLC)
Supelco
ケトコナゾール, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
フェナセチン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
4-ヒドロキシメフェニトイン, ≥98% (HPLC)
Supelco
8-メトキシソラレン, analytical standard
クマリン, primary reference standard
Supelco
クマリン, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
ウンベリフェロン, analytical standard